{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:59Z","timestamp":1786991639239,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005035","name":"BIOTRONIK SE und Co KG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jcin.2023.10.055","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T14:11:56Z","timestamp":1702303916000},"page":"2900-2914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Head-to-Head Comparison of 2\u00a0Paclitaxel-Coated Balloons for\u00a0Femoropopliteal Lesions"],"prefix":"10.1016","volume":"16","author":[{"given":"Koen R.","family":"Deloose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Lansink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Brodmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Keirse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5457-8807","authenticated-orcid":false,"given":"Yann","family":"Gou\u00ebffic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Verbist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Maene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen M.H.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ducasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Levent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Sauguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Vandael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Vercauteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joren","family":"Callaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcin.2023.10.055_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1526602817710770","article-title":"Six-month results from the initial randomized study of the ranger paclitaxel-coated balloon in the femoropopliteal segment","volume":"24","author":"Bausback","year":"2017","journal-title":"J\u00a0Endovasc Ther"},{"issue":"1","key":"10.1016\/j.jcin.2023.10.055_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1526602817745565","article-title":"Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan randomized trial","volume":"25","author":"Iida","year":"2018","journal-title":"J\u00a0Endovasc Ther"},{"issue":"12","key":"10.1016\/j.jcin.2023.10.055_bib3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and\u00a0pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jcin.2023.10.055_bib4","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jcin.2023.10.055_bib5","first-page":"45","article-title":"Treatment of femoropopliteal atherosclerotic lesions using the ranger paclitaxel-coated balloon catheter: 12-month results from an all-comers registry","volume":"59","author":"Lichtenberg","year":"2017","journal-title":"J\u00a0Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.jcin.2023.10.055_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcin.2013.01.128","article-title":"2-Year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry","volume":"6","author":"Micari","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"2","key":"10.1016\/j.jcin.2023.10.055_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jcin.2023.10.055_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"1","key":"10.1016\/j.jcin.2023.10.055_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"issue":"7","key":"10.1016\/j.jcin.2023.10.055_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcin.2015.12.267","article-title":"Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry","volume":"9","author":"Schmidt","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"2","key":"10.1016\/j.jcin.2023.10.055_bib11","first-page":"278","article-title":"Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study","volume":"86","author":"Schroeder","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.jcin.2023.10.055_bib12","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","volume":"135","author":"Schroeder","year":"2017","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jcin.2023.10.055_bib13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00270-017-1713-2","article-title":"Angiographic and clinical outcomes after treatment of femoro-popliteal lesions with a novel paclitaxel-matrix-coated balloon catheter","volume":"40","author":"Tepe","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"10.1016\/j.jcin.2023.10.055_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease 12-month results from the IN.PACT SFA randomized Trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jcin.2023.10.055_bib15","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jcin.2017.04.041","article-title":"The 24-month results of the Lutonix Global SFA Registry: worldwide experience with Lutonix drug-coated balloon","volume":"10","author":"Thieme","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"3","key":"10.1016\/j.jcin.2023.10.055_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1583\/13-4630MR.1","article-title":"Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions","volume":"21","author":"Zeller","year":"2014","journal-title":"J\u00a0Endovasc Ther"},{"issue":"24","key":"10.1016\/j.jcin.2023.10.055_bib17","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"26","key":"10.1016\/j.jcin.2023.10.055_bib19","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.jcin.2023.10.055_bib20","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jcin.2023.10.055_bib21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejvs.2019.12.034","article-title":"Editor\u2019s choice - long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis","volume":"59","author":"Behrendt","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"10.1016\/j.jcin.2023.10.055_bib22","article-title":"Survival and causes of death among veterans with lower extremity revascularization with paclitaxel-coated devices: insights from the Veterans Health Administration","volume":"10","author":"Gutierrez","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jcin.2023.10.055_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012074","article-title":"Update from the longitudinal assessment of safety of femoropopliteal endovascular treatment with paclitaxel-coated devices among Medicare beneficiaries: the SAFE-PAD study","volume":"15","author":"Secemsky","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"issue":"27","key":"10.1016\/j.jcin.2023.10.055_bib24","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehaa049","article-title":"COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions","volume":"41","author":"Steiner","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2023.10.055_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ahj.2018.12.012","article-title":"Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND study","volume":"209","author":"Sammy","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2023.10.055_bib26","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.122.059646","article-title":"Randomized trial of Chocolate Touch compared with Lutonix drug-coated balloon in femoropopliteal lesions (Chocolate Touch study)","volume":"145","author":"Shishehbor","year":"2022","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.jcin.2023.10.055_bib27","first-page":"2093","article-title":"Low-dose vs high-dose paclitaxel-coated balloons for femoropopliteal lesions: 2-year results from the COMPARE trial","volume":"15","author":"Steiner","year":"2020","journal-title":"Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.jcin.2023.10.055_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00270-020-02663-7","article-title":"Paclitaxel-coated balloon angioplasty for the treatment of infrainguinal arteries: 24-month outcomes in the full cohort of BIOLUX P-III Global Registry","volume":"44","author":"Tepe","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"12","key":"10.1016\/j.jcin.2023.10.055_bib29","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00270-022-03259-z","volume":"45","author":"Deloose","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"10.1016\/j.jcin.2023.10.055_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000117","article-title":"Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing","volume":"1","author":"Granada","year":"2014","journal-title":"Open Heart"},{"issue":"6","key":"10.1016\/j.jcin.2023.10.055_bib31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4244\/EIJV7I6A116","article-title":"Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients","volume":"7","author":"Radke","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2023.10.055_bib32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1160\/TH10-11-0698","article-title":"Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis","volume":"105","author":"Joner","year":"2011","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.jcin.2023.10.055_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0885328211423784","article-title":"Preclinical evaluation of a novel drug-eluting balloon in an animal model of in-stent stenosis","volume":"27","author":"Joner","year":"2013","journal-title":"J\u00a0Biomater Appl"},{"key":"10.1016\/j.jcin.2023.10.055_bib34","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2017.04.024","article-title":"Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents: a randomized controlled trial","volume":"10","author":"Kufner","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2023.10.055_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrcardio.2013.165","article-title":"Drug-coated balloon therapy in coronary and peripheral artery disease","volume":"11","author":"Byrne","year":"2014","journal-title":"Nat Rev Cardiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879823014760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879823014760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:19:09Z","timestamp":1761848349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879823014760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":34,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1936879823014760"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2023.10.055","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Head-to-Head Comparison of 2\u00a0Paclitaxel-Coated Balloons for\u00a0Femoropopliteal Lesions","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2023.10.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}